Lipoprotein(a) and the risk of atrial fibrillation – is there a link
| 1 | Department of Hypertension, WAM, University Hospital in Lodz, Medical University of Lodz, Zeromskiego 113, 90-549 Lodz, Poland |
| 2 | School of Pharmacy & Biomolecular Sciences, Liverpool John Moores University, Byrom Street, Liverpool, L3 3AF, UK |
CORRESPONDING AUTHOR
Maciej Banach
Department of Hypertension, WAM, University Hospital in Lodz, Medical University of Lodz, Zeromskiego 113, 90-549 Lodz, Poland
Department of Hypertension, WAM, University Hospital in Lodz, Medical University of Lodz, Zeromskiego 113, 90-549 Lodz, Poland
Publication date: 2017-12-29
Heart Beat 2017;2:49–50
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.